Literature DB >> 7617823

Prolonged but not acute fluoxetine administration produces its inhibitory effect on hippocampal seizures in rats.

Y Wada1, J Shiraishi, M Nakamura, H Hasegawa.   

Abstract

This study assessed the effects of acute as well as long-term administration of fluoxetine, a selective serotonin (5-HT) reuptake inhibitor with anti-depressant properties, on hippocampal (HIP) seizures elicited by electrical stimulation in rats. The fluoxetine effect on HIP seizures was also assessed following long-term treatment with gepirone, a 5-HT1A receptor agonist. Acute single administration of fluoxetine (1, 10 mg/kg; IP) was found to produce no significant effect on HIP seizure activity. Following daily IP administration of fluoxetine (10 mg/kg per day) or gepirone (10 mg/kg per day) for 21 days, animals were given a 7-day drug-free period and then challenged with an acute dose of 10 mg/kg fluoxetine. These treatment regimens resulted in a significantly increased afterdischarge threshold of HIP seizures in response to acute fluoxetine administration. The inhibitory effect of fluoxetine, however, was not present 4 weeks after long-term treatment with either fluoxetine or gepirone. The present results indicate that long-term treatment with these compounds enhances the antiepileptic effect of subsequent fluoxetine administration on the generation of HIP seizures. This effect is possibly related to the well-demonstrated evidence that fluoxetine and gepirone, on long-term treatment, facilitate net 5-HT neurotransmission through desensitization of presynaptic 5-HT autoreceptors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7617823     DOI: 10.1007/BF02245959

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  34 in total

1.  Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei.

Authors:  N Bel; F Artigas
Journal:  Synapse       Date:  1993-11       Impact factor: 2.562

2.  A 5-HT1A ligand with both antidepressant and anxiolytic properties.

Authors:  J M Cott; N M Kurtz; D S Robinson; S P Lancaster; J E Copp
Journal:  Psychopharmacol Bull       Date:  1988

3.  Electrophysiological investigations on the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat.

Authors:  P Blier; C De Montigny
Journal:  J Neurosci       Date:  1983-06       Impact factor: 6.167

4.  Effect of median raphe stimulation on hippocampal seizure discharge induced by carbachol in the rabbit.

Authors:  H Nishi; S Watanabe; S Ueki
Journal:  Jpn J Pharmacol       Date:  1980-10

5.  Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain.

Authors:  Y Chaput; C de Montigny; P Blier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-08       Impact factor: 3.000

6.  Stereoselective blockade at [3H]5-HT binding sites and at the 5-HT autoreceptor by propranolol.

Authors:  D N Middlemiss
Journal:  Eur J Pharmacol       Date:  1984-06-01       Impact factor: 4.432

7.  Fluoxetine, a selective serotonin-uptake inhibitor, enhances the anticonvulsant effects of phenytoin, carbamazepine, and ameltolide (LY201116).

Authors:  J D Leander
Journal:  Epilepsia       Date:  1992 May-Jun       Impact factor: 5.864

8.  Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats.

Authors:  Q S Yan; P C Jobe; J W Dailey
Journal:  Eur J Pharmacol       Date:  1994-01-24       Impact factor: 4.432

9.  Gepirone in anxiety: a pilot study.

Authors:  I Csanalosi; E Schweizer; W G Case; K Rickels
Journal:  J Clin Psychopharmacol       Date:  1987-02       Impact factor: 3.153

10.  Differential effect of gepirone on presynaptic and postsynaptic serotonin receptors: single-cell recording studies.

Authors:  P Blier; C de Montigny
Journal:  J Clin Psychopharmacol       Date:  1990-06       Impact factor: 3.153

View more
  12 in total

1.  Successful treatment of epilepsy with serotonin reuptake inhibitors: proposed mechanism.

Authors:  C Albano; A Cupello; P Mainardi; S Scarrone; E Favale
Journal:  Neurochem Res       Date:  2006-05-13       Impact factor: 3.996

Review 2.  Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?

Authors:  L Cardamone; M R Salzberg; T J O'Brien; N C Jones
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

Review 3.  Bidirectional Relations Among Depression, Migraine, and Epilepsy: Do They Have an Impact on Their Response to Treatment?

Authors:  Andres M Kanner
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 4.  Serotonin Selective Reuptake Inhibitors (SSRIs) and Stroke.

Authors:  F Chollet; J Rigal; P Marque; M Barbieux-Guillot; N Raposo; V Fabry; J F Albucher; J Pariente; I Loubinoux
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-23       Impact factor: 5.081

Review 5.  From unwitnessed fatality to witnessed rescue: Pharmacologic intervention in sudden unexpected death in epilepsy.

Authors:  George B Richerson; Detlev Boison; Carl L Faingold; Philippe Ryvlin
Journal:  Epilepsia       Date:  2016-01       Impact factor: 5.864

6.  Epileptic seizures but not pseudoseizures are associated with decreased density of the serotonin transporter in blood platelet membranes.

Authors:  Aroldo Cupello; Daniela Audenino; Simona Scarrone; Michele Fornaro; Elena Gatta; Pantaleo Fornaro; Claudio Albano
Journal:  Neurochem Res       Date:  2008-04-22       Impact factor: 3.996

Review 7.  Therapeutic potential of fluoxetine in neurological disorders.

Authors:  Jop P Mostert; Marcus W Koch; Marco Heerings; Dorothea J Heersema; Jacques De Keyser
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

8.  Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine.

Authors:  Andréy Mazarati; Prabha Siddarth; Roger A Baldwin; Don Shin; Rochelle Caplan; Raman Sankar
Journal:  Brain       Date:  2008-06-17       Impact factor: 13.501

9.  A ketogenic diet protects DBA/1 and Scn1aR1407X/+ mice against seizure-induced respiratory arrest independent of ketosis.

Authors:  Megan S Crotts; YuJaung Kim; Eduardo Bravo; George B Richerson; Frida A Teran
Journal:  Epilepsy Behav       Date:  2021-09-29       Impact factor: 2.937

10.  Inhibition of hyperactivity of the dorsal raphe 5-HTergic neurons ameliorates hippocampal seizure.

Authors:  Heming Cheng; Yingbei Qi; Nanxi Lai; Lin Yang; Cenglin Xu; Shuang Wang; Yi Guo; Zhong Chen; Yi Wang
Journal:  CNS Neurosci Ther       Date:  2021-05-06       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.